[ Price : $8.95]
Serina Therapeutics files a complete response to an FDA clinical hold on SER-252, the companys lead investigational therapy for ad...[ Price : $8.95]
FDA weighs changes to a long-standing labeling rule for dietary supplements and will temporarily exercise enforcement discretion o...[ Price : $8.95]
FDA releases the form FDA-483 with two observations from an inspection at the Astellas Pharma sterile drug manufacturing facility ...[ Price : $8.95]
Eli Lillys investigational triple-agonist retatrutide shows substantial weight loss and meaningful reductions in knee osteoarthrit...[ Price : $8.95]
Cardiovascular Business reports that the American College of Cardiology has joined numerous other healthcare organizations in aski...[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) and its use in combination with AVD...[ Price : $8.95]
The U.S. government urges the Supreme Court to take up a patent-infringement dispute to decide whether generic drugmakers may face...[ Price : $8.95]
Researchers say that the enhanced FDA regulatory authority from the 2017 FDA Amendments Act did not significantly change the time ...